AlphaRx to License Anticancer Toxin from Select Therapeutics
By Business Review Editor
Pharma Deals Review: Vol 2002 Issue 31 (Table of Contents)
Published: 2 Dec-2002
DOI: 10.3833/pdr.v2002.i31.965 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
AlphaRx licensed the rights to a putative anticancer compound VeroPulse™ from Select Therapeutics...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS